A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000908
Collaborator
(none)
250
54
4.6

Study Details

Study Description

Brief Summary

The purpose of this study is to see how often Pneumocystis carinii pneumonia (PCP) occurs in HIV-positive patients who have stopped taking medications that help prevent PCP.

The risk of developing PCP may be decreased when an HIV-positive patient's CD4 cell counts (cells of the immune system which fight infection) are more than 200 cells/mm3. This study looks at whether it is acceptable to stop PCP prevention treatment in these patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The risk of developing PCP may be decreased with treatment-induced recovery of CD4 counts to

    200 cells/mm3. Few data exist to confirm or negate the continued necessity of PCP prophylaxis for such patients. This study will assess the effects of discontinuing therapy.

    Subjects are asked to discontinue PCP prophylaxis if antiretroviral therapy has resulted in a sustained CD4 increase greater than 200 cells/mm3 on two measurements at least 12 weeks apart. They will be evaluated for symptoms and CD4 counts every 8 weeks as well as plasma for HIV-RNA every 16 weeks for 18 months. Subjects whose CD4 count falls to less than 150 cells/mm3 or between 150 and 200 cells/mm3 will have the CD4 count re-evaluated immediately or within 4 weeks. If the second CD4 count is less than 200 cells/mm3 for either case, conventional PCP prophylaxis will be resumed and the subject will be followed on study. Subjects will be followed during study by physical exams and laboratory tests at Weeks 4, 8, and every 8 weeks thereafter.

    Study Design

    Study Type:
    Observational
    Observational Model:
    Natural History
    Official Title:
    Impact of Discontinuing PCP Prophylaxis in Subjects Receiving Antiretroviral Therapies Who Have Had Increases in CD4 Counts to > 200 Cells/mm3

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      13 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No

      Inclusion Criteria

      You may be eligible for this study if you:
      • Are HIV-positive.

      • Have had 1 CD4 cell count of less than 100 cells/mm3 and have never had PCP, or have had at least 2 CD4 cell counts over 200 cells/mm3 and have had PCP within 6 months prior to study entry.

      • Have received PCP prevention medication within 3 months of study entry.

      • Are at least 13 years old (need consent if under 18).

      • Are taking anti-HIV (antiretroviral) medication at study entry.

      Exclusion Criteria

      You will not be eligible for this study if you:
      • Have active PCP or symptoms of PCP within 2 weeks of study entry.

      • Have a fever lasting more than 2 weeks.

      • Have oral candidiasis (thrush).

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Univ of Alabama at Birmingham Birmingham Alabama United States 35294
      2 Kaiser Foundation Hosp Harbor City California United States 90710
      3 Kaiser Permanente LAMC Los Angeles California United States 90027
      4 Univ of Southern California / LA County USC Med Ctr Los Angeles California United States 900331079
      5 Willow Clinic Menlo Park California United States 94025
      6 Univ of California / San Diego Treatment Ctr San Diego California United States 921036325
      7 San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco California United States 941102859
      8 San Francisco Gen Hosp San Francisco California United States 941102859
      9 Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium San Jose California United States 951282699
      10 Marin County Specialty Clinic San Rafael California United States 94903
      11 San Mateo AIDS Program / Stanford Univ Stanford California United States 943055107
      12 Stanford Univ Med Ctr Stanford California United States 943055107
      13 Univ of Colorado Health Sciences Ctr Denver Colorado United States 80262
      14 Howard Univ Washington District of Columbia United States 20059
      15 Univ of Miami School of Medicine Miami Florida United States 331361013
      16 Emory Univ Atlanta Georgia United States 30308
      17 Queens Med Ctr Honolulu Hawaii United States 96816
      18 Univ of Hawaii / Leahi Hosp Honolulu Hawaii United States 96816
      19 Northwestern Univ Med School Chicago Illinois United States 60611
      20 Cook County Hosp Chicago Illinois United States 60612
      21 Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois United States 60612
      22 Louis A Weiss Memorial Hosp Chicago Illinois United States 60640
      23 Indiana Univ Hosp Indianapolis Indiana United States 462025250
      24 Division of Inf Diseases/ Indiana Univ Hosp Indianapolis Indiana United States 46202
      25 Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana United States 46202
      26 Johns Hopkins Hosp Baltimore Maryland United States 21287
      27 Harvard (Massachusetts Gen Hosp) Boston Massachusetts United States 02114
      28 Boston Med Ctr Boston Massachusetts United States 02118
      29 Beth Israel Deaconess - West Campus Boston Massachusetts United States 02215
      30 Beth Israel Deaconess Med Ctr Boston Massachusetts United States 02215
      31 Univ of Minnesota Minneapolis Minnesota United States 55455
      32 St Louis Regional Hosp / St Louis Regional Med Ctr St. Louis Missouri United States 63112
      33 Univ of Nebraska Med Ctr Omaha Nebraska United States 681985130
      34 SUNY / Erie County Med Ctr at Buffalo Buffalo New York United States 14215
      35 Beth Israel Med Ctr New York New York United States 10003
      36 Bellevue Hosp / New York Univ Med Ctr New York New York United States 10016
      37 Chelsea Ctr New York New York United States 10021
      38 Cornell Univ Med Ctr New York New York United States 10021
      39 Mount Sinai Med Ctr New York New York United States 10029
      40 St Mary's Hosp (Univ of Rochester/Infectious Diseases) Rochester New York United States 14642
      41 Univ of Rochester Medical Center Rochester New York United States 14642
      42 Univ of North Carolina Chapel Hill North Carolina United States 275997215
      43 Duke Univ Med Ctr Durham North Carolina United States 27710
      44 Univ of Cincinnati Cincinnati Ohio United States 452670405
      45 Univ of Kentucky Lexington Cincinnati Ohio United States 45267
      46 Case Western Reserve Univ Cleveland Ohio United States 44106
      47 MetroHealth Med Ctr Cleveland Ohio United States 441091998
      48 Ohio State Univ Hosp Clinic Columbus Ohio United States 432101228
      49 Philadelphia Veterans Administration Med Ctr Philadelphia Pennsylvania United States 19104
      50 Univ of Pennsylvania at Philadelphia Philadelphia Pennsylvania United States 19104
      51 Univ of Pittsburgh Med Ctr Pittsburgh Pennsylvania United States 15213
      52 Julio Arroyo West Columbia South Carolina United States 29169
      53 Univ of Washington Seattle Washington United States 98104
      54 Univ of Puerto Rico San Juan Puerto Rico 009365067

      Sponsors and Collaborators

      • National Institute of Allergy and Infectious Diseases (NIAID)

      Investigators

      • Study Chair: Susan Koletar,
      • Study Chair: Alison Heald,
      • Study Chair: Robert Murphy,

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00000908
      Other Study ID Numbers:
      • ACTG 888
      First Posted:
      Aug 31, 2001
      Last Update Posted:
      Jun 24, 2005
      Last Verified:
      Feb 1, 2003

      Study Results

      No Results Posted as of Jun 24, 2005